Region: Global   
You are not logged in    Login
The Information Resource for the Healthcare Industry!
Free Bronze Listing
Browse Healthcare Products & Suppliers by Category
Browse Healthcare Whitepapers by Sector
Browse Healthcare Events By Category
Participation Option 1
Interested in Exhibiting
Submit Events
About IDS-Healthcare
Submit News

  Paper Details                 Browse papers by sector
Risk Management System for Schedule II Controlled Substances
Author            :Allan Wilson, MD, PhD
Designation    :Professor
Company        :University of Ottawa
 Biography  Synopsis   Download Paper

Send your queries and feedback on this paper by contacting the author.

Synopsis

Opiate analgesics are widely accepted as best practice in the management of chronic pain syndromes. Unfortunately, such medications have high dependence liability, putting them at risk for abuse.

Chronic pain is estimated to affect 35 percent of the population at some point in their lives. Chronic pain has various definitions. Two such definitions are “Pain of three months or six months duration” and “Persistence of pain beyond what is medically expected”. The most common etiologies are degenerative joint and disc disease, rheumatoid arthritis and other spondyleomyopathies, hemarthroses, pain associated with chronic illnesses such as cancer and collagen vascular diseases, and diabetic and other neuropathies.


Industry IDS, Inc. UK eHealth Association ISIPS Health On the Net Foundation European Union of Medical Specialists
DELEGATES
      19880      
Conference Sectors  Case Studies  List of Papers  Exhibition Sectors  Vendor Presentation  List of Exhibitors  Industry News  Sponsors  All Exhibitors  All Papers  Sitemap  Registration Links ]

 :: IDS Emergency Management :: IDS Water ::IDS Publishing / Media::IDS Packaging::IDS Environment::IDS Plastics::IDS Power/Energy:: 

Industry IDS, Inc. – Online Tradeshow, Exhibition, & Buyers Guide Solutions